To study the effect of haritaki (terminalia chebula) in spring season as an adjuvant in health promotio
Phase 2
- Registration Number
- CTRI/2024/07/071653
- Lead Sponsor
- Dr Sushma T J
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Healthy volunteers of age group 20-40 years irrespective of genders.
2) Participants with bio chemical parameters in concern within normal range
3) Participants willing to give a written consent
Exclusion Criteria
1) Subjects with any systemic illness
2) Subjects contraindicated for Haritaki administration7
3) Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improved Hb, TC, DC, ESRTimepoint: 40th day
- Secondary Outcome Measures
Name Time Method Maintenance of improved Hb, TC, DC, ESRTimepoint: 60th day